Feb 19, 2019 7:00 am EST NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
Jan 28, 2019 7:00 am EST NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
Dec 12, 2018 7:35 am EST NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder
Dec 11, 2018 4:10 pm EST NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
Nov 30, 2018 5:01 pm EST QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
Oct 1, 2018 7:00 am EDT NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018
